Research & Publications

Molecular Biology: Measuring and Reporting BCR-ABL Transcripts Level
Giuseppe Saglio

Relative Risk (Sokal & Hasford): Relationship with Treatment Results
Michele Baccarani

Imatinib in the Early Chronic Phase
Richard Larson

Diagnostic and Pre-treatment Work-up
François Guilhot

Long-term benefit of imatinib for patients newly diagnosed with CML in chronic phase: The 5-year update from IRIS study
Brian J. Druker

Response-related Prognostic Factors: The Cytogenetic Response
Michael Deininger

Response-related Prognostic Factors: The Molecular Response
Giuseppe Saglio

Bcr-Abl Kinase Domain Mutations
Martin Müller

Response Definition, Evaluation and Monitoring
Michele Baccarani

Treatment Policy
Rüdiger Hehlmann

Venice Meeting Highlights: Key lessons
Michele Baccarani, Rüdiger Hehlmann